← Back to NEO

NEOGENOMICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 28/10/2026Jun 2026Filed 28/10/2026Mar 2026Filed 28/10/2026Sep 2025Filed 28/10/2026Jun 2025Filed 28/10/2026Mar 2025Filed 28/10/2026Sep 2024Filed 28/10/2025Jun 2024Filed 28/10/2025
$209$202$187$188$181$168$168$165
−$7.5$2.2−$17−$27−$45−$26−$18−$19
129131129128128127127126

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.